# Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

> **NCT00931957** · NA · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Behcet Syndrome
- Uveal Disease

## Interventions

- **DRUG:** Etanercept, Methotrexate, Prednisolone

## Key facts

- **NCT ID:** NCT00931957
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2012-10
- **Final completion:** 2013-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931957, "Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00931957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*